This has been most firmly established in the gastrointestinal tract, where mutations in the Wnt pathway component, APC and to a lesser degree in β-catenin, activate signalling and are associated with the majority of colon cancers [1], [2], [3]. Here, APC is linked to malignant colon neoplasm.